FDA Inspection 1025778 — Innovative Blood Resources

Innovative Blood Resources — FEI 2177737

The FDA completed an inspection of Innovative Blood Resources on August 18, 2017 in Virginia, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Virginia, MN (United States)